Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors
Reads0
Chats0
TLDR
The correlation between biochemical and in vitro data strongly supports Hsp90 as a drug target against the malaria parasite, and suggests that the best hit represents a promising scaffold to develop parasite specific leads.Abstract:
The recent reduction in mortality due to malaria is being threatened by the appearance of Plasmodium falciparum parasites that are resistant to artemisinin in Southeast Asia. To limit the impact of resistant parasites and their spread across the world, there is a need to validate anti-malarial drug targets and identify new leads that will serve as foundations for future drug development programmes targeting malaria. Towards that end, the antiplasmodial potential of several Hsp90 inhibitors was characterized. Because, the Hsp90 chaperone has been suggested as a good drug target against multiple parasitic infections including malaria. Chemically diverse sets of Hsp90 inhibitors, evaluated in clinical trials as anti-cancer agents, were tested against the malaria parasite. Most of the compounds showed strong antiplasmodial activity in growth inhibition assays against chloroquine sensitive and resistant strains. There was a good agreement between the compound in vitro anti-parasitic activity and their affinity against the Plasmodium chaperone. The two most potent Hsp90 inhibitors also showed cytocidal activity against two P. falciparum strains. Their antiplasmodial activity affected all parasite forms during the malaria blood cycle. However, the compounds activity against the parasite showed no synergy when combined with anti-malarial drugs, like chloroquine or DHA. The Hsp90 inhibitors anti-parasitic activity correlates with their affinity to their predicted target the P. falciparum chaperone Hsp90. However, the most effective compounds also showed high affinity for a close homologue, Grp94. This association points to a mode of action for Hsp90 inhibitors that correlate compound efficacy with multi-target engagement. Besides their ability to limit parasite replication, two compounds also significantly impacted P. falciparum viability in vitro. Finally, a structural analysis suggests that the best hit represents a promising scaffold to develop parasite specific leads according. The results shown that Hsp90 inhibitors are lethal against the malaria parasite. The correlation between biochemical and in vitro data strongly supports Hsp90 as a drug target against the malaria parasite. Furthermore, at least one Hsp90 inhibitor developed as anticancer therapeutics could serve as starting point to generate P. falciparum-specific lead compounds.read more
Citations
More filters
Journal ArticleDOI
Small Molecule Inhibitors Targeting the Heat Shock Protein System of Human Obligate Protozoan Parasites
Tawanda Zininga,Addmore Shonhai +1 more
TL;DR: The current review highlights the progress made so far in design and application of small molecule inhibitors against obligate intracellular human parasites of the kinetoplastida and apicomplexan kingdoms.
Journal ArticleDOI
Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.
Sue Jin Moon,Sue Jin Moon,Byong Chang Jeong,Hwa Jin Kim,Hwa Jin Kim,Joung Eun Lim,Hye Jeong Kim,Ghee Young Kwon,Joshua A. Jackman,Jeong Hoon Kim,Jeong Hoon Kim +10 more
TL;DR: It is suggested that bruceantin (BCT) could serve as a promising therapeutic candidate against CRPC and highlight the potential benefit of targeting AR-FL/AR-V7-HSP90 axis to overcome resistance caused by aberrant AR-Fl/AR -V7 signaling.
Journal ArticleDOI
A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90.
Luana Carneiro Palma,Luiz Felipe Gomes Rebello Ferreira,Antonio Luis de Oliveira Almeida Petersen,Beatriz Rocha Simões Dias,Juliana Perrone Bezerra de Menezes,Diogo Rodrigo Magalhães Moreira,Marcelo Zaldini Hernandes,Patrícia Sampaio Tavares Veras +7 more
TL;DR: The present findings demonstrate potential for the use of these inhibitors in the context of anti-Leishmania therapy and propose that geldanamycin, 17-AAG and 17-DMAG present an increased tendency to bind to the N-terminal domain of Leishmania amazonensis Hsp83 in comparison to human Hsp90.
Journal ArticleDOI
Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds.
Nieves Martinez-Peinado,Clara Martori,Nuria Cortes-Serra,Julian Sherman,Ana Rodriguez,Joaquim Gascon,Jordi Alberola,María-Jesús Pinazo,Alhelí Rodríguez-Cortés,Julio Alonso-Padilla +9 more
TL;DR: In this paper, the authors evaluated the specific anti-T. cruzi activity of nine bio-energetic modulator compounds and found that 17-DMAG, which targets the ATP-binding site of heat shock protein 90 (Hsp90), has a very high (sub-micromolar range) selective inhibition of the parasite growth.
Journal ArticleDOI
Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins
Jessica A. Engel,Emma L. Norris,Paul R. Gilson,Jude M. Przyborski,Addmore Shonhai,Gregory L. Blatch,Tina S. Skinner-Adams,Jeffrey J. Gorman,Madeleine J. Headlam,Katherine T. Andrews +9 more
TL;DR: A proteomics analysis of PfHDAC1 immunoprecipitates is presented, identifying 26 putative P. falciparum complex proteins in trophozoite-stage asexual intraerythrocytic parasites and the co-migration of two of these with Pf HDAC1 was validated using Blue Native PAGE combined with Western blot.
References
More filters
Journal ArticleDOI
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
Oleg Trott,Arthur J. Olson +1 more
TL;DR: AutoDock Vina achieves an approximately two orders of magnitude speed‐up compared with the molecular docking software previously developed in the lab, while also significantly improving the accuracy of the binding mode predictions, judging by tests on the training set used in AutoDock 4 development.
Journal ArticleDOI
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Garrett M. Morris,Ruth Huey,William Lindstrom,Michel F. Sanner,Richard K. Belew,David S. Goodsell,Arthur J. Olson +6 more
TL;DR: AutoDock4 incorporates limited flexibility in the receptor and its utility in analysis of covalently bound ligands is reported, using both a grid‐based docking method and a modification of the flexible sidechain technique.
Journal ArticleDOI
Molecular chaperones in protein folding and proteostasis
TL;DR: It is suggested that an age-related decline in proteostasis capacity allows the manifestation of various protein-aggregation diseases, including Alzheimer's disease and Parkinson's disease, which may spring from a detailed understanding of the pathways underlying proteome maintenance.
Journal ArticleDOI
Drug repositioning: identifying and developing new uses for existing drugs
Ted T. Ashburn,Karl B. Thor +1 more
TL;DR: Repositioning existing drugs for new indications could deliver the productivity increases that the industry needs while shifting the locus of production to biotechnology companies.
Journal ArticleDOI
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Samir Bhatt,Daniel J. Weiss,Ewan Cameron,Donal Bisanzio,Bonnie Mappin,Ursula Dalrymple,Katherine E. Battle,Catherine L. Moyes,Andrew J. Henry,Philip A. Eckhoff,Edward Allen Wenger,Olivier J T Briët,Olivier J T Briët,Melissa A. Penny,Melissa A. Penny,Thomas J. Smith,Thomas J. Smith,Adam Bennett,Joshua Yukich,Thomas P. Eisele,Jamie T. Griffin,Cristin A Fergus,Michael Lynch,Finn Lindgren,Justin M. Cohen,C L J Murray,David L. Smith,Simon I. Hay,Simon I. Hay,Simon I. Hay,Richard E Cibulskis,Peter W. Gething +31 more
TL;DR: It is found that Plasmodium falciparum infection prevalence in endemic Africa halved and the incidence of clinical disease fell by 40% between 2000 and 2015, and interventions have averted 663 (542–753 credible interval) million clinical cases since 2000.
Related Papers (5)
A novel approach for the discovery of chemically diverse anti-malarial compounds targeting the Plasmodium falciparum Coenzyme A synthesis pathway
Sabine Fletcher,Vicky M. Avery +1 more
Cyclopropyl Carboxamides, a Chemically Novel Class of Antimalarial Agents Identified in a Phenotypic Screen
Laura M. Sanz,M. Belen Jiménez-Díaz,Benigno Crespo,Cristina De-Cozar,M. Jesus Almela,Iñigo Angulo-Barturen,Pablo Castañeda,Javier Ibáñez,Esther Fernández,Santiago Ferrer,Esperanza Herreros,Sonia Lozano,María Santos Martínez,Lourdes Rueda,Jeremy N. Burrows,Jose F. Garcia-Bustos,Francisco-Javier Gamo +16 more